Physician profile
Christopher James Johnson
NPI 1487620993
$554,830.61
in general payments reported to CMS, 2019-2025
23 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $39K · 2021: $85K · 2022: $89K · 2023: $108K · 2024: $93K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $212K · Travel and Lodging: $28K · Food and Beverage: $3,921 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Gift: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $212,050.00 |
| Travel and Lodging | $28,255.94 |
| Food and Beverage | $3,920.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Gift | $219.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $552,577.72 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Covidien LP | $917.12 | 2019 | |
| Medical Device Business Services, INC. | $295.93 | 2019 | |
| Smith+Nephew, INC. | $150.38 | 2021 | |
| Averitas Pharma INC. | $121.11 | 2023 | Qutenza |
| Allergan, INC. | $104.52 | 2020-2022 | |
| Integra Lifesciences Corporation | $95.65 | 2022 | |
| Tela Bio, INC. | $85.45 | 2022-2024 | Ovitex 2s |
| Davol INC. | $84.41 | 2019-2020 | |
| Endogastric Solutions, INC | $74.46 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $67.28 | 2020-2022 | |
| Cook Medical LLC | $56.70 | 2019 | |
| Ethicon US, LLC | $33.46 | 2019-2020 | |
| Baxter Healthcare | $24.10 | 2022 | |
| Abbvie INC. | $23.42 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $18.53 | 2021 | |
| Innocoll Pharmaceuticals Limited | $16.32 | 2021 | |
| Checkpoint Surgical, INC | $15.28 | 2019 | |
| Teleflex LLC | $15.03 | 2021 | |
| Boston Scientific Corporation | $14.67 | 2024 | Spyglass Discover |
| Sanara Medtech INC. | $14.24 | 2023 | Celleraterx |
| Shire North American Group INC | $13.30 | 2019 | |
| Focal Therapeutics, INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.